Sciencast Management’s Lunai Bioworks LNAI Stock Holding History

Sciencast Management’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-194	Closed	-$133K	–	626
2022 Q1	$133K	Buy	+194	New	+$103K	0.03%	446

Other funds holding LNAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sciencast Management's LNAI Position: Q2 2022 in Review

Sciencast Management sold out of Lunai Bioworks (LNAI) in Q2 2022, closing a stake of 194 shares — an estimated $133K sold.

Sciencast Management first reported a position in LNAI in Q1 2022 and held it in 1 quarter. The position peaked at $133K in Q1 2022. 51 funds tracked by Wall St. Rank hold LNAI as of Q2 2022.

Sciencast Management reported no remaining Lunai Bioworks position as of Q2 2022 after selling out during the quarter.
Sciencast Management sold 194 Lunai Bioworks shares in Q2 2022, an estimated $133K.
Sciencast Management first reported a position in Lunai Bioworks in Q1 2022 and held it in 1 quarter.
Sciencast Management's Lunai Bioworks position peaked at $133K in Q1 2022.
51 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.